Cold Genesys' Arthur Kuan Is Helping To Reinvent The Way We Approach Cancer | Forbes
February 17, 2020
5,018
70
6
1.51%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Forbes Episodes Around February 17, 2020
See what was published immediately before and after this episode.
2:33Now PlayingCold Genesys' Arthur Kuan Is Helping To Reinvent The Way We Approach Cancer | Forbes
YouTube Description
as posted by the channelArthur Kuan is going viral. He's the CEO of Santa Ana, CA biotech company Cold Genesys, which genetically modifies viruses to attack cancer and, as a bonus, bolsters your immune system against it. The venture investor encountered Cold Genesys as a founding member at Hong Kong healthcare fund Ally Bridge Group. Fascinated by the science, Kuan, who holds a master's degree in biotechnology from Johns Hopkins, joined Cold Genesys as COO. When founder Alex Yeung retired left in 2016, Kuan took over. He's since launched clinical trials of the biotech's bladder cancer treatment and has signed a partnership to test its effectiveness with Merck's immunotherapy drug Keytruda. "I've done a good job turning this science story into a real business concept," Kuan says. In March, he closed a $22 million Series C round led by ORI Capital with the China-based medical device maker Lepu Medical, which has the China license for its products.
Read more about the 30 Under 30 honorees in healthcare on Forbes
Subscribe to FORBES
Stay Connected
Forbes newsletters
Forbes on Facebook
Forbes Video on Twitter
Forbes Video on Instagram
More From Forbes
Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.